Subscription banner for an ophthalmic newsletter
Schirmer's Test and Its Implications in Monitoring and Managing Dry Eyes

Schirmer's Test represents a cornerstone in the assessment of tear production, offering insights int...

read more
Schirmer's Test and Its Implications in Monitoring and Managing Dry Eyes
November 22, 2023
Telios Pharma's TL-925 Shows Promise in Dry Eye Disease Treatment

Telios Pharma, Inc. announced promising topline results from its Phase 2 study of TL-925, a pioneeri...

read more
Telios Pharma's TL-925 Shows Promise in Dry Eye Disease Treatment
March 07, 2024
FDA Requests Further Study on Aldeyra Therapeutics’ Reproxalap for DED

Aldeyra Therapeutics announced the receipt of a Complete Response Letter from the U.S. Food and Drug...

read more
FDA Requests Further Study on Aldeyra Therapeutics’ Reproxalap for DED
November 28, 2023
Eyenovia and Senju Pharmaceutical Collaborate on Novel Dry Eye Treatment

Eyenovia, a leading ophthalmic company, announced a collaboration agreement with Senju Pharmaceutica...

read more
Eyenovia and Senju Pharmaceutical Collaborate on Novel Dry Eye Treatment
July 25, 2024
Stuart Therapeutics Completes Phase 3 Trial of Vezocolmitide for Dry Eye Disease

Stuart Therapeutics has announced the successful completion of its Phase 3 clinical trial for ST-100...

read more
Stuart Therapeutics Completes Phase 3 Trial of Vezocolmitide for Dry Eye Disease
January 23, 2025
Novaliq’s Vevizye® Receives Positive CHMP Opinion for Dry Eye Disease

Novaliq announced that the European Medicines Agency’s Committee for Medicinal Products for Human U...

read more
Novaliq’s Vevizye® Receives Positive CHMP Opinion for Dry Eye Disease
July 30, 2024
Eyenovia and SGN Nanopharma Collaborate to Develop Treatment for Chronic Dry Eye Disease

Eyenovia and SGN Nanopharma have announced a new collaboration to develop a treatment for chronic dr...

read more
Eyenovia and SGN Nanopharma Collaborate to Develop Treatment for Chronic Dry Eye Disease
July 31, 2024
CSI Dry Eye Software Releases Version 5.0 Update

CSI Dry Eye Software, a leading innovator in the field of artificial intelligence for eye care, has ...

read more
CSI Dry Eye Software Releases Version 5.0 Update
April 02, 2024
Bausch + Lomb Launches Dry Eye Drug Miebo in the U.S.

Bausch + Lomb has officially launched Miebo (perfluorohexyloctane ophthalmic solution) for the treat...

read more
Bausch + Lomb Launches Dry Eye Drug Miebo in the U.S.
September 13, 2023
5 Best Eye Drops for Dry Eyes

Dry eyes can be a real nuisance, causing discomfort and irritation. Thankfully, there's a wide range...

read more
5 Best Eye Drops for Dry Eyes
September 15, 2023
More